Genomic Vision announced the appointment of Frederic Hammel as Chief Operating Officer, further strengthening its leadership team. Frederic is an accomplished operational manager with more than 25 years of experience in the healthcare industry. Before joining Genomic Vision he was the CEO of Ethera, a company that produces in air-quality products.

Prior to that, he held the position of CEO at Platine Pharma Services SAS (later acquired by a company of Bio Mérieux), a contract research organization focused on immune monitoring and validation of diagnostic immune assays and of TxCell, a clinical-stage biotech developing cell-based immunotherapies. At Genomic Vision, Frederic will be responsible for managing all operational aspects of the company. Frederic will be supported in his role by the newly appointed Director of Human Resources, Claire Fleury.

She brings more than 20 years of experience in human resources, most recently at real estate company Group Horizon, and holds a BSc in Psychology from Université de Reims-Champagne Ardennes, France and a Master's in Human Resources and Management from the University of Geneva, Switzerland. In her new role Claire will oversee Genomic Vision's HR activities.